Neuraura

Neuraura was founded in 2017, by Claire Dixon, Colin Dalton, and Pierre Wijdenes.

The company's initial clinical product is a brain monitoring platform designed for epilepsy surgery comprised of proprietary electrodes, wireless EEG hardware and 3D visualization software. The company looks to improve patient experience, outcomes, and reduce the costs of a healthcare system. The product leverages their proprietary microsensors and the unique electrophysiological data set from epilepsy patients to unlock neuromodulation for widespread applications.

The stated goal of Neuraura is to put an end to brain diseases and associated stigma. Their brain platform is designed to help neurologists and neurosurgeons make decisions through granular electrophysiological brain data. This data can lead to neuromodulation devices that can communicate with the brain. The company provides their product to healthcare, information technology, medical, and medical device markets.

Neuraura was the first recipient of the Tecterra LEAP program.